» Articles » PMID: 35190943

Patients' and Providers' Views on Optimal Evidence-Based and Scalable Interventions for Individuals at High Risk of HIV Treatment Failure: Sequential Explorations Among Key Stakeholders in Cape Town, South Africa

Abstract

To support translation of evidence-based interventions into practice for HIV patients at high risk of treatment failure, we conducted qualitative research in Cape Town, South Africa. After local health officials vetted interventions as potentially scalable, we held 41 in-depth interviews with patients with elevated viral load or a 3-month treatment gap at community clinics, followed by focus group discussions (FGDs) with 20 providers (physicians/nurses, counselors, and community health care workers). Interviews queried treatment barriers, solutions, and specific intervention options, including motivational text messages, data-informed counseling, individual counseling, peer support groups, check-in texts, and treatment buddies. Based on patients' preferences, motivational texts and treatment buddies were removed from consideration in subsequent FGDs. Patients most preferred peer support groups and check-in texts while individual counseling garnered the broadest support among providers. Check-in texts, peer support groups, and data-informed counseling were also endorsed by provider sub-groups. These strategies warrant attention for scale-up in South Africa and other resource-constrained settings.

Citing Articles

Stakeholder Priorities for ART Initiation and Early Retention Interventions in Malawi: A Qualitative Study Comparing International and National Perspectives.

Hariprasad S, Phiri K, Thorp M, Holland K, Nyirenda R, Gupta S Res Sq. 2024; .

PMID: 38196656 PMC: 10775367. DOI: 10.21203/rs.3.rs-3725505/v1.


Protocol for an evaluation of adherence monitoring and support interventions among people initiating antiretroviral therapy in Cape Town, South Africa-a multiphase optimization strategy (MOST) approach using a fractional factorial design.

Jennings L, West R, Halim N, Kaiser J, Gwadz M, MacLeod W Trials. 2023; 24(1):310.

PMID: 37147725 PMC: 10163747. DOI: 10.1186/s13063-023-07322-z.

References
1.
Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

2.
Granich R, Williams B, Montaner J . Fifteen million people on antiretroviral treatment by 2015: treatment as prevention. Curr Opin HIV AIDS. 2012; 8(1):41-9. DOI: 10.1097/COH.0b013e32835b80dd. View

3.
Grinsztejn B, Hosseinipour M, Ribaudo H, Swindells S, Eron J, Chen Y . Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014; 14(4):281-90. PMC: 4144040. DOI: 10.1016/S1473-3099(13)70692-3. View

4.
Montague B, Vuylsteke B, Buve A . Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and prevention. BMC Public Health. 2011; 11:701. PMC: 3189888. DOI: 10.1186/1471-2458-11-701. View

5.
Kharsany A, Karim Q . HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J. 2016; 10:34-48. PMC: 4893541. DOI: 10.2174/1874613601610010034. View